arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

Electromed, Inc.

ELMD
$27.70 0.00 (0.00%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
65 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
73
Health
Good
Bullish
auto_awesome

Analytical Summary

Electromed, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth 11.6% ↘
Op. Margin 19.7% ↘
ROIC 6.1% ↗
FCF / Share None
Trailing P/E 67.6x
Price / Book 4.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$19.42M
↑ +11.6% —
Net Income Profit after all expenses
$3.40M
↑ +54.3% —
Operating Margin Operating profit as % of sales
19.7%
↓ -2.8% 82th
FCF / Share Free cash flow per share
$0.41
↑ +40.2% —
Long-Term Debt Long-term obligations
$1.09M
↓ -1.1% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
74
Returns ↑
81
Cash Quality
47

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 65 quarters